Organisation paid for research Program year 2025 Source: CMS Open Payments

Coastal Pediatric Research

Neither a doctor nor a teaching hospital

Research payments

$10,733,448

1,428 payments

Through program year 2025, Coastal Pediatric Research is reported as receiving $10,733,448 in research payments, across 1,428 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $314,180 60
2024 Research $546,690 165
2023 Research $945,764 227
2022 Research $4,833,110 243
2021 Research $2,880,175 175
2020 Research $525,454 193
2019 Research $688,075 365

Breakdown

Who paid Research payments · program years 2019–2025
  1. Moderna TX, Inc. $6,060,790 151 payments
  2. Pfizer Inc. $2,296,910 373 payments
  3. Sanofi Pasteur Inc. $957,807 218 payments
  4. Merck Sharp & Dohme Corporation $441,634 333 payments
  5. AbbVie, Inc. $278,303 116 payments
  6. GlaxoSmithKline, LLC. $138,878 70 payments
  7. Roche Molecular Systems, Inc. $105,303 12 payments
  8. Acrotech Biopharma LLC $83,098 10 payments
  9. Shire North American Group Inc $78,278 23 payments
  10. AstraZeneca Pharmaceuticals LP $69,927 2 payments
Studies the money was for Research payments · program years 2019–2025
  1. A Phase 2/3, Two-Part, Open-Label, Dose Escalation, Age De-escalation and Randomized, Observer Blind, Placebo-Controlled Expansion Study to Evaluate the Safety, Tolerability, Reactogenicity, and Effectiveness of mRNA 1273 SARS-CoV-2 Vaccine in Health $4,466,380 92 payments
  2. A Phase 3 Randomized Doubleblinded Placebocontrolled Trial to Evaluate the Efficacy and Safety of A Respiratory Syncytial Virus RSV Prefusion F Subunit Vaccine in Infants Born to Women Vaccinated During Pregnancy $1,317,298 107 payments
  3. A Phase 2/3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adolescents 12 to <18 years of age $1,024,427 19 payments
  4. Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants and Toddlers $389,779 132 payments
  5. A Phase 3 Randomized Doubleblind Trial to Evaluate the Safety of A 20Valent Pneumococcal Conjugate Vaccine in Healthy Infants $278,431 45 payments
  6. An Open-Label, Phase 3 Study to Evaluate the Safety and Immunogenicity of the mRNA1273.214 Vaccine for SARS-CoV-2 Variants of Concern in Participants Aged 6 Months to < 6 Years $254,255 5 payments
  7. Phase 1 Openlabel Dosefinding Study to Evaluate Safety Tolerability and Immunogenicity and Phase 23 Placebocontrolled Observerblinded Safety Tolerability and Immunogenicity Study of A Sarscov2 Rna Vaccine Candidate Against Covid19 in Healthy Children and Young Adults $172,621 40 payments
  8. MET41 A Randomized Study to Describe the Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants and Toddlers $166,950 35 payments
  9. Immunogenicity and Safety of Quadrivalent Recombinant Influenza Vaccine (RIV4) in Children and Adolescents Aged 9 to 17 Years and Adults Aged 18 to 49 Years. $146,341 13 payments
  10. A Phase 3, Multicenter, Randomized, Double-blind Study to Evaluate the Interchangeability of V114 and Prevnar 13 with Respect to Safety, Tolerability, and Immunogenicity in Healthy Infants PNEU-DIRECTION $141,053 32 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record